Literature DB >> 8650246

The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion.

I Kishimoto1, S K Dubois, D L Garbers.   

Abstract

Disruption of guanylyl cyclase-A (GC-A) results in mice displaying an elevated blood pressure, which is not altered by high or low dietary salt. However, atrial natriuretic peptide (ANP), a proposed ligand for GC-A, has been suggested as critical for the maintenance of normal blood pressure during high salt intake. In this report, we show that infusion of ANP results in substantial natriuresis and diuresis in wild-type mice but fails to cause significant changes in sodium excretion or urine output in GC-A-deficient mice. ANP, therefore, appears to signal through GC-A in the kidney. Other natriuretic/diuretic factors could be released from the heart. Therefore, acute volume expansion was used as a means to cause release of granules from the atrium of the heart. That granule release occurred was confirmed by measurements of plasma ANP concentrations, which were markedly elevated in both wild-type and GC-A-null mice. After volume expansion, urine output as well as urinary sodium and cyclic GMP excretion increased rapidly and markedly in wild-type mice, but the rapid increases were abolished in GC-A-deficient animals. These results strongly suggest that natriuretic/diuretic factors released from the heart function exclusively through GC-A.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8650246      PMCID: PMC39216          DOI: 10.1073/pnas.93.12.6215

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands.

Authors:  D L Garbers
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

2.  Effects of HS-142-1, a novel non-peptide ANP antagonist, on diuresis and natriuresis induced by acute volume expansion in anesthetized rats.

Authors:  T Sano; Y Morishita; K Yamada; Y Matsuda
Journal:  Biochem Biophys Res Commun       Date:  1992-01-31       Impact factor: 3.575

3.  Physiological role of silent receptors of atrial natriuretic factor.

Authors:  T Maack; M Suzuki; F A Almeida; D Nussenzveig; R M Scarborough; G A McEnroe; J A Lewicki
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

4.  Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor.

Authors:  D R Nussenzveig; J A Lewicki; T Maack
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

5.  Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system.

Authors:  M B Anand-Srivastava; M R Sairam; M Cantin
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

6.  Atrial natriuretic factor: a hormone produced by the heart.

Authors:  A J de Bold
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

7.  Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; E Morita; N Sakaino; M Jougasaki; M Kurose; M Mukoyama; Y Saito; K Nakao; H Imura
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

8.  Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

Authors:  S Suga; K Nakao; K Hosoda; M Mukoyama; Y Ogawa; G Shirakami; H Arai; Y Saito; Y Kambayashi; K Inouye
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

9.  Urinary guanosine 3':5'-cyclic monophosphate but not tissue kallikrein follows the plasma atrial natriuretic factor response to acute volume expansion with saline.

Authors:  H M Lewis; M R Wilkins; B M Selwyn; U J Yelland; M E Griffith; K D Bhoola
Journal:  Clin Sci (Lond)       Date:  1988-11       Impact factor: 6.124

10.  Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes.

Authors:  S Nakamura; M Naruse; K Naruse; M Kawana; T Nishikawa; S Hosoda; I Tanaka; T Yoshimi; I Yoshihara; T Inagami
Journal:  Am J Hypertens       Date:  1991-11       Impact factor: 2.689

View more
  30 in total

1.  Natriuretic peptide receptors and the heart.

Authors:  L King; M R Wilkins
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Arg13 of B-type natriuretic Peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors.

Authors:  Deborah M Dickey; Kathryn A Barbieri; Christopher M McGuirk; Lincoln R Potter
Journal:  Mol Pharmacol       Date:  2010-06-08       Impact factor: 4.436

Review 3.  The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Authors:  Kailash N Pandey
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

4.  Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.

Authors:  Karim Sabrane; Markus N Kruse; Larissa Fabritz; Bernd Zetsche; Danuta Mitko; Boris V Skryabin; Melanie Zwiener; Hideo A Baba; Masashi Yanagisawa; Michaela Kuhn
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

5.  A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.

Authors:  I Kishimoto; K Rossi; D L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

6.  The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion.

Authors:  Barbara Schreier; Sebastian Börner; Katharina Völker; Stepan Gambaryan; Stephan C Schäfer; Peter Kuhlencordt; Birgit Gassner; Michaela Kuhn
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

7.  Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume.

Authors:  Fitz-Roy E Curry; Cecilie Brekke Rygh; Tine Karlsen; Helge Wiig; Roger H Adamson; Joyce F Clark; Yueh-Chen Lin; Birgit Gassner; Frits Thorsen; Ingrid Moen; Olav Tenstad; Michaela Kuhn; Rolf K Reed
Journal:  J Physiol       Date:  2009-11-30       Impact factor: 5.182

Review 8.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

Authors:  Lincoln R Potter; Andrea R Yoder; Darcy R Flora; Laura K Antos; Deborah M Dickey
Journal:  Handb Exp Pharmacol       Date:  2009

9.  A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation.

Authors:  Deborah M Dickey; Andrea R Yoder; Lincoln R Potter
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

10.  Natriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart.

Authors:  Ichiro Kishimoto; Takeshi Tokudome; Takeshi Horio; David L Garbers; Kazuwa Nakao; Kenji Kangawa
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.